rs7860945

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_133497.4(KCNV2):​c.978C>T​(p.Asp326Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0421 in 1,613,088 control chromosomes in the GnomAD database, including 1,599 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.046 ( 196 hom., cov: 33)
Exomes 𝑓: 0.042 ( 1403 hom. )

Consequence

KCNV2
NM_133497.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.365

Publications

5 publications found
Variant links:
Genes affected
KCNV2 (HGNC:19698): (potassium voltage-gated channel modifier subfamily V member 2) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium voltage-gated channel subfamily V. This member is identified as a 'silent subunit', and it does not form homomultimers, but forms heteromultimers with several other subfamily members. Through obligatory heteromerization, it exerts a function-altering effect on other potassium channel subunits. This protein is strongly expressed in pancreas and has a weaker expression in several other tissues. [provided by RefSeq, Jul 2008]
KCNV2 Gene-Disease associations (from GenCC):
  • cone dystrophy with supernormal rod response
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.097).
BP6
Variant 9-2718717-C-T is Benign according to our data. Variant chr9-2718717-C-T is described in ClinVar as Benign. ClinVar VariationId is 262364.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.365 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0608 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNV2NM_133497.4 linkc.978C>T p.Asp326Asp synonymous_variant Exon 1 of 2 ENST00000382082.4 NP_598004.1 Q8TDN2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNV2ENST00000382082.4 linkc.978C>T p.Asp326Asp synonymous_variant Exon 1 of 2 1 NM_133497.4 ENSP00000371514.3 Q8TDN2
ENSG00000286670ENST00000768783.1 linkn.113+27581G>A intron_variant Intron 1 of 3
ENSG00000286670ENST00000768784.1 linkn.156+13228G>A intron_variant Intron 1 of 3
ENSG00000286670ENST00000768785.1 linkn.156+13228G>A intron_variant Intron 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.0460
AC:
6999
AN:
152228
Hom.:
196
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0629
Gnomad AMI
AF:
0.0800
Gnomad AMR
AF:
0.0343
Gnomad ASJ
AF:
0.0302
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0105
Gnomad FIN
AF:
0.0291
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0478
Gnomad OTH
AF:
0.0363
GnomAD2 exomes
AF:
0.0344
AC:
8584
AN:
249466
AF XY:
0.0331
show subpopulations
Gnomad AFR exome
AF:
0.0647
Gnomad AMR exome
AF:
0.0213
Gnomad ASJ exome
AF:
0.0300
Gnomad EAS exome
AF:
0.0000546
Gnomad FIN exome
AF:
0.0301
Gnomad NFE exome
AF:
0.0472
Gnomad OTH exome
AF:
0.0306
GnomAD4 exome
AF:
0.0417
AC:
60972
AN:
1460742
Hom.:
1403
Cov.:
36
AF XY:
0.0408
AC XY:
29655
AN XY:
726764
show subpopulations
African (AFR)
AF:
0.0632
AC:
2114
AN:
33474
American (AMR)
AF:
0.0230
AC:
1028
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.0306
AC:
798
AN:
26108
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39692
South Asian (SAS)
AF:
0.0120
AC:
1032
AN:
86246
European-Finnish (FIN)
AF:
0.0314
AC:
1647
AN:
52498
Middle Eastern (MID)
AF:
0.00503
AC:
29
AN:
5768
European-Non Finnish (NFE)
AF:
0.0468
AC:
52077
AN:
1111864
Other (OTH)
AF:
0.0372
AC:
2245
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
4554
9108
13663
18217
22771
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1876
3752
5628
7504
9380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0460
AC:
7004
AN:
152346
Hom.:
196
Cov.:
33
AF XY:
0.0432
AC XY:
3216
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.0628
AC:
2610
AN:
41582
American (AMR)
AF:
0.0344
AC:
526
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.0302
AC:
105
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5166
South Asian (SAS)
AF:
0.0106
AC:
51
AN:
4832
European-Finnish (FIN)
AF:
0.0291
AC:
309
AN:
10632
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0478
AC:
3252
AN:
68030
Other (OTH)
AF:
0.0360
AC:
76
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
361
721
1082
1442
1803
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0486
Hom.:
192
Bravo
AF:
0.0478
Asia WGS
AF:
0.00751
AC:
26
AN:
3478
EpiCase
AF:
0.0415
EpiControl
AF:
0.0435

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cone dystrophy with supernormal rod response Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
6.4
DANN
Benign
0.93
PhyloP100
0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7860945; hg19: chr9-2718717; COSMIC: COSV66056469; COSMIC: COSV66056469; API